HEIDI HOPPER: Open Payments
NPI 1174637029 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 20 payments from 12 companies in 2025. Trend: 2023 $883 · 2024 $1,408 · 2025 $409
Food & beverage: $309Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $178 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| TOLMAR, INC. | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Teleflex LLC | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Endo USA, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: ERLEADA, GEMTESA, ELIGARD, PROVENGE, BARRIGEL, ORGOVYX, XTANDI, XIAFLEX.
Industry payments across NE — which companies pay providers there.
